Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06IAR
|
||||
Former ID |
DAP000223
|
||||
Drug Name |
Adenosine
|
||||
Synonyms |
ADN; Adenocard; Adenocor; Adenoscan; Adenosin; Adensoine; Boniton; Myocol; Nucleocardyl; Pallacor;Polyadenosine; Polyriboadenosine; Sandesin; Vidarabine; Adenine nucleoside; Adenine riboside; Adenosin [German]; SR 96225; Ade-Rib; Adenocard (TN); Adenocard, Adenosine; Adenoscan (TN); Adenosine [USAN:BAN]; Adenosine, homopolymer; Beta-Adenosine; MEDR-640; SR-96225; SUN-Y4001; USAF CB-10; Adenine-D-ribose; Adenosine (JAN/USP); Beta-D-Adenosine; Adenine 9-beta-D-arabinofuranoside; Adenine-9-beta-D-ribofuranoside; Beta-D-Ribofuranoside, adenine-9; EA6C60C2-6AFB-4264-A2F0-541373DB950E; (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 9-(beta-D-Arabinofuranosyl)adenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiarrhythmic Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H13N5O4
|
||||
InChI |
InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
|
||||
InChIKey |
OIRDTQYFTABQOQ-KQYNXXCUSA-N
|
||||
CAS Number |
CAS 58-61-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
2103, 3512, 584484, 584490, 585862, 586357, 597013, 819854, 821994, 823447, 825728, 826920, 828107, 828519, 829493, 830178, 830391, 833174, 833907, 836875, 837192, 855078, 855932, 3136392, 7847113, 7885717, 7978645, 8023217, 8024149, 8027268, 8143428, 8187141, 10318629, 11110168, 11120317, 11120805, 11121293, 11371396, 11484930, 11489073, 11490104, 11532406, 11532673, 11537606, 12090919, 14716094, 14774851, 14799162, 22394812, 24277685
|
||||
ChEBI ID |
ChEBI:16335
|
||||
SuperDrug ATC ID |
C01EB10
|
||||
SuperDrug CAS ID |
cas=000058617
|
||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Modulator | [556264] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | C-MYB transcription factor network | ||||
References | |||||
Ref 536838 | Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22. | ||||
Ref 539879 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2844). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.